Publication: Efficacy and Safety of Percutaneous Metallic Mitral Valvuloplasty in Rheumatic Mitral Stenosis at Siriraj Hospital
Issued Date
2002-04-01
Resource Type
ISSN
01252208
Other identifier(s)
2-s2.0-0036526980
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.85, No.4 (2002), 405-415
Suggested Citation
Rewat Phankingthongkum, Chunhakasem Chotinaiwattarakul, Pradit Panchavinnin, Damras Tresukosol, Decho Jakrapanichakul, Yongyuth Sahasakul, Sanya Kaeokam-Aim Efficacy and Safety of Percutaneous Metallic Mitral Valvuloplasty in Rheumatic Mitral Stenosis at Siriraj Hospital. Journal of the Medical Association of Thailand. Vol.85, No.4 (2002), 405-415. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/20506
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Efficacy and Safety of Percutaneous Metallic Mitral Valvuloplasty in Rheumatic Mitral Stenosis at Siriraj Hospital
Other Contributor(s)
Abstract
Mitral stenosis is an important problem that leads to heart failure and stroke in Thailand. The options of treatment at present are either surgical or balloon mitral commissuroiomy. However, the cost of balloon is very expensive. To reduce the expense of the procedure, the authors prospectively did a study using a new device called the metallic valvulotome in symptomatic severe mitral stenosis to assess the safety, feasibility and immediate outcomes. Fifty-seven patients were included in the study. The successful outcome achieved by the metallic valvulotome was 96.2 per cent in patients in whom the procedure was actually performed. The mean transmitral gradient, left atrial pressure and pulmonary artery pressure were significantly decreased and the mitral valve area was also significantly increased. Three cases failed the procedure due to inappropriate position of the septal puncture. No death occurred in the study and complications of the procedure included only two cases of hemopericardium. In the future, it is believed that this new innovative device will provide improvement and reduce the cost of the procedure in patients with severe mitral stenosis.